Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High ACE Activity Plasma for ACEI-induced Angioedema
NCT04679311Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2020
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of High ACE Activity Fresh Frozen Plasma (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Serum Angiotensin Converting Enzyme Activity at 30 months. Started Dec 2020; status: terminated.
02
Drugs
High ACE Activity Fresh Frozen Plasma
Beyond the preview
Go deeper on NCT04679311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04679311.